SEC Form 4 · accession 0001140361-16-046943
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Doug Alleavitch
Officer — VP, Quality and Operations
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jan 4, 2016 | S | 300 | $65.8633 | D | 12,170 | D | |
| Common StockF4 | Jan 4, 2016 | S | 700 | $66.7671 | D | 11,470 | D | |
| Common StockF6 | Jan 4, 2016 | S | 500 | $65.912 | D | 7,704 | I | By spouse |
| Common StockF7 | Jan 4, 2016 | S | 1,014 | $66.7179 | D | 6,690 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.45 to $66.35, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3Includes 470 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 13, 2015.
- F4The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.49 to $67.04, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F5The sale was effected pursuant to the Reporting Person's spouse's Rule 10b5-1 trading plan.
- F6The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $65.38 to $66.29, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F7The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.41 to $67.06, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.